The Developmental Research Projects are an integral component of the Rocky Mountain Regional RCE (RMRCE) strategic plan and research portfolio. A maximum of five developmental projects composed of new and renewal applications will be funded each year for one year with budgets of up to 100K each. These will likely be high risk projects offering potential for the development of novel approaches, reagents, or model systems that will advance biodefense and emerging infectious diseases (EID) research efforts. Developmental Research Projects will also provide critical preliminary data for submission of proposals to diverse funding agencies. These will be used to expand the range and scope of the RMRCE research portfolio, and also to increase the representation of scientists and institutions involved in the RMRCE. The RMRCE will solicit proposals annually from RCE and non-RCE scientists in Region VIII institutions. An RFA will be drafted by the Associate Program Director and approved by the Program Director. The final RFA will then be distributed electronically by the Program Manager to all investigators that have had any involvement in the RMRCE and posted on the RCE Website, as well as to the Vice President for Research Offices of all Region VIII instititions. The latter group will have a unique oversight of all potential RCE participants and programs in their respective institutions and will aid in having the greatest diversity of project proposals submitted. Academic peers, as well as members of the Steering Committee, will review newly proposed Developmental Research Projects. The most promising projects, which are consistent with the strategic plan and program enhancement of the RMRCE and national RCE program, will be selected for funding. Developmental Research Projects previously funded can be resubmitted as a competitive renewal for a second year of funding. If significant new potential for program development is presented after one or two years of funding, the respective Developmental Research Project will be encouraged to submit an application as a full research project to compete for funds made available through the termination of existing but non-productive full research projects. This process will provide maximum flexibility for RMRCE program growth and productivity, and will allow the RMRCE to avail itself of new technologies, talents, and opportunities for program growth, and to address specific needs and goals.

Public Health Relevance

The Developmental Research Projects are an integral part of the RMRCE portfolio as new projects will emerge that provide exciting opportunities for generating new information into fundamental processes that govern the lifestyles and virulence of pathogens, new opportunities to develop therapeutics or vaccines for select agent and priority pathogens, which will potentially benefit the RMRCE and the national biodefense and EID research efforts.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Colorado State University-Fort Collins
Fort Collins
United States
Zip Code
Webb, Jessica R; Price, Erin P; Somprasong, Nawarat et al. (2018) Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei. Future Microbiol 13:1403-1418
York, Joanne; Nunberg, Jack H (2018) A Cell-Cell Fusion Assay to Assess Arenavirus Envelope Glycoprotein Membrane-Fusion Activity. Methods Mol Biol 1604:157-167
Rhodes, Katherine A; Somprasong, Nawarat; Podnecky, Nicole L et al. (2018) Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression. Microbiology 164:1156-1167
Cummings, Jason E; Slayden, Richard A (2017) Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response. PLoS Negl Trop Dis 11:e0005209
Pettey, W B P; Carter, M E; Toth, D J A et al. (2017) Constructing Ebola transmission chains from West Africa and estimating model parameters using internet sources. Epidemiol Infect 145:1993-2002
Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463
Skyberg, Jerod A; Lacey, Carolyn A (2017) Hematopoietic MyD88 and IL-18 are essential for IFN-?-dependent restriction of type A Francisella tularensis infection. J Leukoc Biol 102:1441-1450
Plumley, Brooke A; Martin, Kevin H; Borlee, Grace I et al. (2017) Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase. J Bacteriol 199:
Randall, Linnell B; Georgi, Enrico; Genzel, Gelimer H et al. (2017) Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance. J Antimicrob Chemother 72:1258-1260
Podnecky, Nicole L; Rhodes, Katherine A; Mima, Takehiko et al. (2017) Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm. MBio 8:

Showing the most recent 10 out of 258 publications